222 related articles for article (PubMed ID: 36806762)
1. Variability and magnitude of brain glutamate levels in schizophrenia: a meta and mega-analysis.
Merritt K; McCutcheon RA; Aleman A; Ashley S; Beck K; Block W; Bloemen OJN; Borgan F; Boules C; Bustillo JR; Capizzano AA; Coughlin JM; David A; de la Fuente-Sandoval C; Demjaha A; Dempster K; Do KQ; Du F; Falkai P; Galińska-Skok B; Gallinat J; Gasparovic C; Ginestet CE; Goto N; Graff-Guerrero A; Ho BC; Howes O; Jauhar S; Jeon P; Kato T; Kaufmann CA; Kegeles LS; Keshavan MS; Kim SY; King B; Kunugi H; Lauriello J; León-Ortiz P; Liemburg E; Mcilwain ME; Modinos G; Mouchlianitis E; Nakamura J; Nenadic I; Öngür D; Ota M; Palaniyappan L; Pantelis C; Patel T; Plitman E; Posporelis S; Purdon SE; Reichenbach JR; Renshaw PF; Reyes-Madrigal F; Russell BR; Sawa A; Schaefer M; Shungu DC; Smesny S; Stanley JA; Stone J; Szulc A; Taylor R; Thakkar KN; Théberge J; Tibbo PG; van Amelsvoort T; Walecki J; Williamson PC; Wood SJ; Xin L; Yamasue H; McGuire P; Egerton A;
Mol Psychiatry; 2023 May; 28(5):2039-2048. PubMed ID: 36806762
[TBL] [Abstract][Full Text] [Related]
2. Association of Age, Antipsychotic Medication, and Symptom Severity in Schizophrenia With Proton Magnetic Resonance Spectroscopy Brain Glutamate Level: A Mega-analysis of Individual Participant-Level Data.
Merritt K; McGuire PK; Egerton A; ; Aleman A; Block W; Bloemen OJN; Borgan F; Bustillo JR; Capizzano AA; Coughlin JM; De la Fuente-Sandoval C; Demjaha A; Dempster K; Do KQ; Du F; Falkai P; Galinska-Skok B; Gallinat J; Gasparovic C; Ginestet CE; Goto N; Graff-Guerrero A; Ho BC; Howes OD; Jauhar S; Jeon P; Kato T; Kaufmann CA; Kegeles LS; Keshavan M; Kim SY; Kunugi H; Lauriello J; Liemburg EJ; Mcilwain ME; Modinos G; Mouchlianitis ED; Nakamura J; Nenadic I; Öngür D; Ota M; Palaniyappan L; Pantelis C; Plitman E; Posporelis S; Purdon SE; Reichenbach JR; Renshaw PF; Russell BR; Sawa A; Schaefer M; Shungu DC; Smesny S; Stanley JA; Stone JM; Szulc A; Taylor R; Thakkar K; Théberge J; Tibbo PG; van Amelsvoort T; Walecki J; Williamson PC; Wood SJ; Xin L; Yamasue H
JAMA Psychiatry; 2021 Jun; 78(6):667-681. PubMed ID: 33881460
[TBL] [Abstract][Full Text] [Related]
3. Nature of Glutamate Alterations in Schizophrenia: A Meta-analysis of Proton Magnetic Resonance Spectroscopy Studies.
Merritt K; Egerton A; Kempton MJ; Taylor MJ; McGuire PK
JAMA Psychiatry; 2016 Jul; 73(7):665-74. PubMed ID: 27304221
[TBL] [Abstract][Full Text] [Related]
4. Glutamate in dorsolateral prefrontal cortex and auditory verbal hallucinations in patients with schizophrenia: A
Ćurčić-Blake B; Bais L; Sibeijn-Kuiper A; Pijnenborg HM; Knegtering H; Liemburg E; Aleman A
Prog Neuropsychopharmacol Biol Psychiatry; 2017 Aug; 78():132-139. PubMed ID: 28546056
[TBL] [Abstract][Full Text] [Related]
5. Glutamate in the Dorsolateral Prefrontal Cortex in Patients With Schizophrenia: A Meta-analysis of
Kaminski J; Mascarell-Maricic L; Fukuda Y; Katthagen T; Heinz A; Schlagenhauf F
Biol Psychiatry; 2021 Feb; 89(3):270-277. PubMed ID: 33129486
[TBL] [Abstract][Full Text] [Related]
6. Glutamatergic and GABAergic metabolite levels in schizophrenia-spectrum disorders: a meta-analysis of
Nakahara T; Tsugawa S; Noda Y; Ueno F; Honda S; Kinjo M; Segawa H; Hondo N; Mori Y; Watanabe H; Nakahara K; Yoshida K; Wada M; Tarumi R; Iwata Y; Plitman E; Moriguchi S; de la Fuente-Sandoval C; Uchida H; Mimura M; Graff-Guerrero A; Nakajima S
Mol Psychiatry; 2022 Jan; 27(1):744-757. PubMed ID: 34584230
[TBL] [Abstract][Full Text] [Related]
7. Dopamine and glutamate in individuals at high risk for psychosis: a meta-analysis of in vivo imaging findings and their variability compared to controls.
McCutcheon RA; Merritt K; Howes OD
World Psychiatry; 2021 Oct; 20(3):405-416. PubMed ID: 34505389
[TBL] [Abstract][Full Text] [Related]
8. Elevated prefrontal cortex γ-aminobutyric acid and glutamate-glutamine levels in schizophrenia measured in vivo with proton magnetic resonance spectroscopy.
Kegeles LS; Mao X; Stanford AD; Girgis R; Ojeil N; Xu X; Gil R; Slifstein M; Abi-Dargham A; Lisanby SH; Shungu DC
Arch Gen Psychiatry; 2012 May; 69(5):449-59. PubMed ID: 22213769
[TBL] [Abstract][Full Text] [Related]
9. Glutamatergic neurometabolite levels in major depressive disorder: a systematic review and meta-analysis of proton magnetic resonance spectroscopy studies.
Moriguchi S; Takamiya A; Noda Y; Horita N; Wada M; Tsugawa S; Plitman E; Sano Y; Tarumi R; ElSalhy M; Katayama N; Ogyu K; Miyazaki T; Kishimoto T; Graff-Guerrero A; Meyer JH; Blumberger DM; Daskalakis ZJ; Mimura M; Nakajima S
Mol Psychiatry; 2019 Jul; 24(7):952-964. PubMed ID: 30315224
[TBL] [Abstract][Full Text] [Related]
10. Reduced frontal glutamate + glutamine and N-acetylaspartate levels in patients with chronic schizophrenia but not in those at clinical high risk for psychosis or with first-episode schizophrenia.
Natsubori T; Inoue H; Abe O; Takano Y; Iwashiro N; Aoki Y; Koike S; Yahata N; Katsura M; Gonoi W; Sasaki H; Takao H; Kasai K; Yamasue H
Schizophr Bull; 2014 Sep; 40(5):1128-39. PubMed ID: 24023251
[TBL] [Abstract][Full Text] [Related]
11. Decoupling of N-acetyl-aspartate and glutamate within the dorsolateral prefrontal cortex in schizophrenia.
Coughlin JM; Tanaka T; Marsman A; Wang H; Bonekamp S; Kim PK; Higgs C; Varvaris M; Edden RA; Pomper M; Schretlen D; Barker PB; Sawa A
Curr Mol Med; 2015; 15(2):176-83. PubMed ID: 25732147
[TBL] [Abstract][Full Text] [Related]
12. In vivo gamma-aminobutyric acid and glutamate levels in people with first-episode schizophrenia: A proton magnetic resonance spectroscopy study.
Chiu PW; Lui SSY; Hung KSY; Chan RCK; Chan Q; Sham PC; Cheung EFC; Mak HKF
Schizophr Res; 2018 Mar; 193():295-303. PubMed ID: 28751130
[TBL] [Abstract][Full Text] [Related]
13. Supplementation of Antipsychotic Treatment with the Amino Acid Sarcosine Influences Proton Magnetic Resonance Spectroscopy Parameters in Left Frontal White Matter in Patients with Schizophrenia.
Strzelecki D; Podgórski M; Kałużyńska O; Gawlik-Kotelnicka O; Stefańczyk L; Kotlicka-Antczak M; Gmitrowicz A; Grzelak P
Nutrients; 2015 Oct; 7(10):8767-82. PubMed ID: 26506383
[TBL] [Abstract][Full Text] [Related]
14. Nature of glutamate alterations in substance dependence: A systematic review and meta-analysis of proton magnetic resonance spectroscopy studies.
Chen T; Tan H; Lei H; Li X; Wu Q; Xu X; Ye Y; Zhong N; Du J; Jiang H; Su H; Zhao M
Psychiatry Res Neuroimaging; 2021 Sep; 315():111329. PubMed ID: 34271295
[TBL] [Abstract][Full Text] [Related]
15. 7T Proton Magnetic Resonance Spectroscopy of Gamma-Aminobutyric Acid, Glutamate, and Glutamine Reveals Altered Concentrations in Patients With Schizophrenia and Healthy Siblings.
Thakkar KN; Rösler L; Wijnen JP; Boer VO; Klomp DW; Cahn W; Kahn RS; Neggers SF
Biol Psychiatry; 2017 Mar; 81(6):525-535. PubMed ID: 27316853
[TBL] [Abstract][Full Text] [Related]
16. Effect of L-theanine on glutamatergic function in patients with schizophrenia.
Ota M; Wakabayashi C; Sato N; Hori H; Hattori K; Teraishi T; Ozawa H; Okubo T; Kunugi H
Acta Neuropsychiatr; 2015 Oct; 27(5):291-6. PubMed ID: 25896423
[TBL] [Abstract][Full Text] [Related]
17. Intra-Regional Glu-GABA vs Inter-Regional Glu-Glu Imbalance: A 1H-MRS Study of the Neurochemistry of Auditory Verbal Hallucinations in Schizophrenia.
Hjelmervik H; Craven AR; Sinceviciute I; Johnsen E; Kompus K; Bless JJ; Kroken RA; Løberg EM; Ersland L; Grüner R; Hugdahl K
Schizophr Bull; 2020 Apr; 46(3):633-642. PubMed ID: 31626702
[TBL] [Abstract][Full Text] [Related]
18. Increased glutamate + glutamine levels in the thalamus of patients with essential tremor: A preliminary proton MR spectroscopic study.
Barbagallo G; Arabia G; Novellino F; Nisticò R; Salsone M; Morelli M; Rocca F; Quattrone A; Caracciolo M; Sabatini U; Cherubini A; Quattrone A
Parkinsonism Relat Disord; 2018 Feb; 47():57-63. PubMed ID: 29203059
[TBL] [Abstract][Full Text] [Related]
19. Excitatory and inhibitory responses in the brain to experimental pain: A systematic review of MR spectroscopy studies.
Archibald J; MacMillan EL; Enzler A; Jutzeler CR; Schweinhardt P; Kramer JLK
Neuroimage; 2020 Jul; 215():116794. PubMed ID: 32278899
[TBL] [Abstract][Full Text] [Related]
20. Glutamatergic changes in the cerebral white matter associated with schizophrenic exacerbation.
Ota M; Ishikawa M; Sato N; Hori H; Sasayama D; Hattori K; Teraishi T; Nakata Y; Kunugi H
Acta Psychiatr Scand; 2012 Jul; 126(1):72-8. PubMed ID: 22432602
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
